ERBB2 and breast cancer: A subset study from the National Cancer Database demonstrated that the pCR rates were 30.2% for HER2-low TNBC and 33.4% for HER2 IHC score 0 TNBC15; however, only OS was reported, without data on breast cancer recurrence, and other studies to date have not definitively addressed this critical question.